Market Updates

Panelists Spotlight Key Regulatory Issues at FDA-OCRA Educational Conference


The session, “CFSAN and Industry Update," will feature an update from the FDA about industry hot topics, including the agency’s current regulatory priorities.

Two leading experts from the Natural Products Association (NPA) will participate in a panel session discussing key regulatory issues at the 16th Annual FDA-OCRA Educational Conference on Thursday, June 13th at 8:00 PM. Cara Welch, Ph.D., senior vice president of scientific and regulatory affairs, and Vicki Whitsitt, scientific and regulatory affairs manager, join Daniel Fabricant, Ph.D., director of the division of dietary supplement programs for the Food and Drug Administration (FDA), and Michael McGuffin, president of the American Herbal Products Association, during the session, “CFSAN and Industry Update.”
 
The session will feature an update from the FDA about industry hot topics, including the agency’s current regulatory priorities. In addition, the experts from the two industry associations will address the challenges facing dietary supplement companies both on Capitol Hill and on the regulatory front. While Good Manufacturing Practices (GMPs) continue to be at the forefront of FDA activities, it’s not just about GMPs — speakers also will touch on topics such as Adverse Event Reporting (AER), the draft New Dietary Ingredient (NDI) guidance, proposed rules under the Food Safety Modernization Act (FSMA), imports/exports of supplement ingredients, the challenge of adulterated ingredients, and more.
 
The FDA-OCRA Educational Conference is an educational conference co-sponsored by the FDA to promote interaction between Los Angeles area professionals and Washington, D.C.-based FDA personnel. The conference will be held from June 12th -13th at the Irvine Marriott in Irvine, CA. Registration for the event is available at www.ocra-dg.org.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters